MedTrace Logo

Echocardiographic Changes After 3-hydroxy Butyrate+Whey Intake

NCT04037722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-06-11

No results posted yet for this study

Summary

This study evaluates the cardiovascular effects of adding the ketone body 3-hydroxy butyrate (3-OHB) to whey protein during human endotoxemia. Further, this study compares cardiovascular changes during healthy and catabolic conditions.

Participants will receive isocaloric, isonitrogenous beverages of either whey or 3-OHB+whey in a randomized crossover design during either healthy (overnight fast) or catabolic conditions (inflammation/endotoxemia + 36 h fast and bed rest).

Conditions

  • Cardiac Output
  • Endotoxemia
  • Catabolic State
  • Echocardiography

Interventions

DIETARY_SUPPLEMENT

Whey

45 g whey + 20 g maltodextrin

DIETARY_SUPPLEMENT

3-OHB + Whey

50 g ketone + 45 g whey + 20 g maltodextrin

Sponsors & Collaborators

  • Arla Food Ingredients, Arla Viby.

    collaborator UNKNOWN

  • Aarhus University Hospital Skejby

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Niels Moeller, Professor · Aarhus University Hospital and Institute of Clinical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2020-01-23
Completion
2020-01-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04037722 on ClinicalTrials.gov